Lundbeck Seattle Biopharmaceuticals Revenue, Growth & Competitor Profile

DBA ALDER BIOPHARMACEUTICALS, INC.

Company Profile & Annual Report for Lundbeck Seattle Biopharmaceuticals

Access the complete profile.

Lundbeck Seattle Biopharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	11804 N Creek Parkway S Bothell, WA 98011

Lundbeck Seattle Biopharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lundbeck Seattle Biopharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Lundbeck Seattle Biopharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Lundbeck Seattle Biopharmaceuticals is a publicly traded company on NGM using the ticker symbol ALDR. Detailed information on company financials and operating reports can be found here: NGM: ALDR

Lundbeck Seattle Biopharmaceuticals Annual Revenue and Growth Rate

Lundbeck Seattle Biopharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lundbeck Seattle Biopharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Lundbeck Seattle Biopharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 26, 2018	6	38%	$260 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Lundbeck Seattle Biopharmaceuticals is developing and marketing. Lundbeck Seattle Biopharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
C VYEPTI CONNECT NURSE SUPPORT Providing patient support services in the field of healthcare and pharmaceuticals in the nature of providing a website featuring medical information via a patient support program in the field of healthcare and pharmaceuticals, namely, prescribing information, medication guidance, medication use, safety information, and information relating to appointment scheduling and reminder support; providing patient support services, namely, providing medical information in the field of medication guidance, prescribing information, assistance with medication use, safety information, answering questions about prescriptions, facilitating prescription filling, and liaising between the pharmacy and the patient	06/15/2023
MIGRAINE MOODS Providing temporary use of online, non-downloadable computer software for making reference image and story boards, namely, software for organizing and referencing inspirational material, images and quotes; software as a service (SAAS) services featuring software for users to create image and story boards for posting on social media; providing a website featuring technology that enables users to create, save and share reference image and story boards for expressing their experiences	11/05/2020

See all trademarks and details in the Full Report.

Market Share of Lundbeck Seattle Biopharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lundbeck Seattle Biopharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Lundbeck Seattle Biopharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOLIFE SOLUTIONS	Bothell, WA	100
LUNDBECK SEATTLE BIOPHARMACEUTICALS	Bothell, WA	16
SOUND PRESCRIPTIONS	Bellevue, WA	2
KEY COMPOUNDING PHARMACY	Federal Way, WA	2
CAAMTECH	Issaquah, WA	1
DYNASTY PHARMACEUTICALS	Lynnwood, WA	1

Future Competition: Lundbeck Seattle Biopharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Lundbeck Seattle Biopharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)